The latest updates on Ozempic, Mounjaro, Wegovy and GLP-1 treatments
Eurofarma announced a significant price reduction for its semaglutide treatment Poviztra, potentially expanding access to GLP-1 therapy for Brazilian patients who previously faced high costs.
Can temperature fluctuations ruin your GLP-1 weight loss pen during long trips? Here's what the stability data says about storing Ozempic, Mounjaro, and similar medications while traveling.
Brazilian patients seeking tirzepatide face a frustrating reality: neighboring countries have found ways to make this medication accessible, while Brazil's regulatory landscape leaves patients without legal access.
Wondering when you might need to pause your semaglutide treatment and what happens to your body during a break? Here's what the medical evidence shows.
Dosing errors with GLP-1 pens can happen to anyone. Here's what you need to know about taking too much, too little, or missing a dose of your weight loss medication.
Wondering if your Brazilian health plan has to cover Ozempic or Mounjaro? Here is what the ANS rules actually determine about GLP-1 medication coverage and what patients can do.
Rapid weight loss from GLP-1 medications can affect body composition. Here's what science says about keeping your muscle intact while shedding fat with injectable pens.
Wondering if adding workouts to your Ozempic routine actually helps? Here's what science says about combining exercise with GLP-1 medications for better weight loss results.
Tirzepatide often produces noticeable weight changes within the first few weeks of treatment. Understanding why this happens can help you set realistic expectations and stay motivated throughout your journey.
GLP-1 and Mental Health: Emotional Eating, Anxiety, and Binge Eating There is a cycle that many people know all too well. They are not truly hungry, yet they open the fridge without knowing exactly what they are looking for. They start eating without real pleasure, almost as if it were a tas.
Semaglutide and Cardiovascular Risk: What the SELECT Study Showed in 2026 For years, the medical community knew that semaglutide helped patients with type 2 diabetes lose weight and control blood sugar. What nobody expected was that the medication would have a profound effect on the hearts of.
Answer a few quick questions and get tailored guidance for your treatment.
or download the app
